[1]
2021. Evaluation of Ischemia Modified Albumin IMA as New Predictor in Patients with Newly Thyroid Dysfunction in Type 2 Diabetes Mellitus. Medico Legal Update. 21, 2 (Mar. 2021), 1426–1431. DOI:https://doi.org/10.37506/mlu.v21i2.2892.